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cDITORIAL COMMENT
essons From Cardiopulmonary
esting After Device Closure of
ecundum Atrial Septal Defects
Tale of Two Ventricles*
ary D. Webb, MD, FRCP(C), FACC,
ric M. Horlick, MD
oronto, Canada
here has been much controversy during the past 50 years
s to which patients with secundum atrial septal defects
ASDs) should have them repaired. Because there was little
vidence to support a mortality benefit, a morbidity advan-
age, or a clear and objective functional improvement after
urgical closure, many physicians and patients waited until
ymptoms developed before seeking the surgeon’s help.
uch reluctance was reinforced by the necessary conse-
uences of surgical ASD repair—an incision and a scar, a
eriod of pain and discomfort, the need for convalescence,
nd exposure to cardiopulmonary bypass. The fact that 75%
f ASD patients were female made it even more common
ot to recommend surgery for asymptomatic patients.
See page 1886
The era of device closure of ASDs has arrived, and data
n outcomes of this relatively new form of therapy are
ccumulating. It is of interest that, at least in some places,
he availability of closure by device seems to have caused an
pidemic of secundum ASDs. Cardiac surgeons at Toronto
eneral Hospital performed about 30 secundum ASD
losures annually until 1998. Our group at the same hospital
as received almost 200 referrals for closure of ASD by
evice in the past year, an experience also reported by
thers. What promises to be the “better mousetrap” repre-
ented by device closure of ASD is being enthusiastically
eceived. Closure of a secundum ASD by device is an easy
ell, but what do we know of its effects, especially in the
arge number of adult patients who have few or no symp-
oms?
It is clear that the right heart can remodel quite quickly
fter closure of an ASD by device. Veldtman et al. (1)
erformed a clinical and echo study of 40 consecutive adult
atients age 20 to 71 years (mean age, 38 years), 95% of
hom were asymptomatic or minimally symptomatic.
ithin one month of closure of ASD by device, they noted
n important reduction in echo-measured right ventricular
*Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.fFrom the Toronto General Hospital, Toronto, Ontario, Canada.RV) dimensions as well as the disappearance of paradoxical
eptal motion (60% to 5%) in most patients. By six months,
ight atrial size was smaller, and there had been normaliza-
ion of echo-measured pulmonary artery systolic pressure in
0% of those in whom it had been elevated. Recently,
rochu et al. (2) studied 37 asymptomatic or mildly symp-
omatic adults undergoing closure of secundum ASDs by
evice. At baseline and using standard echo measures, the
V was severely dilated in 21, mildly dilated in 14, and of
ormal dimensions in two patients. Six months after device
cclusion, the RV was severely dilated in one, mildly dilated
n 17, and of normal size in 17 patients.
After closure, dilated RVs often returned to normal size,
ut objective measures of improved cardiopulmonary per-
ormance were lacking until recently. Brochu et al. (2)
eported the results of cardiopulmonary exercise testing on
7 adults undergoing closure of secundum ASDs by device
o investigate whether there were beneficial changes in
xercise capacity and RV function in patients who were
symptomatic or mildly symptomatic before the procedure
2). They demonstrated a rise in mean peak oxygen con-
umption (peak VO2) after ASD closure from 23.5  6.4
l/kg/min to 26.9  6.9 (15%) ml/kg/min. Interestingly,
he increase was as significant in New York Heart Associ-
tion (NYHA) functional class I patients (22%) as it was
n NYHA functional class II patients (12%). The NYHA
unctional class I patients normalized their performance
hen compared with age-matched controls, whereas
YHA functional class II patients significantly improved
heir performance. Six patients had a normal peak VO2 at
aseline (three patients diagnosed as class I, and three
iagnosed as class II). Five of these six patients increased
heir oxygen uptake at follow-up. They found a consistent
verall improvement in peak oxygen uptake both in patients
lder than 40 and in patients younger than 40 and in those
ith left-to-right shunt sizes both above and below 2:1.
ubjectively, 15 of 37 patients were diagnosed as NYHA
unctional class I before the procedure, improving to 35 of
7 patients at six-month follow-up. The Brochu et al. (2)
tudy was the first major study in adults to show a prompt
mprovement in functional capacity after closure of ASD by
evice.
In this issue of the Journal, Giardini et al. (3) report a
mall but careful study of cardiopulmonary exercise testing,
pirometry, and echocardiography in 32 adults (mean age,
2  16.7 years) before and six months after percutaneous
evice closure of their secundum ASDs. This study’s im-
ortant contribution lies in its clarification of the mecha-
isms underlying the cardiopulmonary improvement in
dults after closure of ASD by device. The population of the
iardini et al. study (3) also was clinically well. Of their
atients, 84% were diagnosed as NYHA functional class I at
he beginning of the study, and 16% were NYHA functional
lass II; 91% experienced an improved peak VO2 at
ollow-up (21.9  10.3 ml/kg/min before closure and 25.6

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May 19, 2004:1892–3 Editorial Comment9.9 ml/kg/min after closure, p  0.0001). After ASD
losure, increases in peak oxygen uptake were observed in
atients of all ages regardless of pre-procedural shunt size,
einforcing the observations of the Brochu et al. (2) study.
he Giardini et al. report (3) also showed a significant
ncrease in left ventricular ejection fraction (LVEF) by the
eicholz method and left ventricular end diastolic diameter
LVEDD) without any change in left ventricular end
ystolic diameter (LVESD) after closure. Peak oxygen
ptake and peak oxygen pulse improvement after closure
orrelated with increases in both LVEF and LVEDD, but
VESD did not increase.
Thus, the Giardini et al. report (3) adds to our under-
tanding of the mechanisms underlying the functional
mprovement of these patients. The increased LVEF and
VEDD in the presence of an unchanged LVESD indicate
hat an increased LV stroke volume accompanies the in-
reased oxygen consumption after closure by device. Their
nding that the oxygen pulse, an indirect marker of stroke
olume, is also increased reinforces the evidence that im-
roved LV filling and systemic cardiac output underlie
uch of the clinical improvement. This report reminds us
hat patients with unrepaired ASDs have a low systemic
ardiac output state that is improved with device closure of
SD. Although the historical focus has been on the
xcessive pulmonary blood flow in ASD patients, we are
eminded that this occurs at the expense of systemic blood
ow, which is in fact chronically subnormal. Overall, the
atients in this study, mildly symptomatic at worst, im-
roved after closure by device because of improved systemic
ardiac output with exercise.
Another important issue is glimpsed in the Giardini et al.
3) report. The precipitation of heart failure in two patients
n this series after closure by device deserves comment and
note of caution. Patients with left heart dysfunction and a
ecundum ASD should receive special scrutiny. It has not
een uncommon in ASD device series to have a few patients
o into pulmonary edema soon after closure by device (4).
andidate patients may have either systolic or diastolic left
eart dysfunction. Typical heart-failure management strat-
gies will usually settle things down, but occasionally a
atient encounters significant acute morbidity. We need
ore information to identify these candidate patients and
larify their long-term outcomes after closure by device.
ome of these patients may need special preparation and
ptimization before closure to ensure a safe outcome. Other
atients with left heart dysfunction should not have their
SDs closed.
Other notes of caution must be added. Device closure of
SDs can be complicated; therefore, a methodical case
election process should be followed. There should be
vidence that the ASD is large enough to have volume-
oaded the right heart. There must be careful screening of
andidates for device closure to ensure that the ASD isechnically suitable and to exclude patients with anomalous
ulmonary venous return who require surgical correction.
e strongly recommend that devices for closure of ASD be
nserted by individuals with sufficient training and experi-
nce to keep risks to a minimum. Such operators will, unlike
olleagues without special training, have the skills needed to
eal safely with technical issues when they do occur. Chessa
t al. (5) recently reported 36 (8.6%) complications in 417
atients undergoing closure by device. Their review of the
iterature demonstrated a major complication rate of 4%
22/599). The closure of ASDs by device carries a major
omplication rate equal to or greater than that of complex
oronary angioplasty.
Overall, there is a positive message here for asymptomatic
nd mildly symptomatic patients with a hemodynamically
mportant secundum ASD. Closure by device can be un-
ertaken safely and can be expected to lead to a reduction in
ize of dilated right heart chambers and an improved
xercise capacity based on an enhanced cardiac output.
here is every reason to believe these benefits, if they occur
n the individual patient, will be long-lasting. It is also likely
hat treatment of the asymptomatic or minimally symptom-
tic patient, as in the studies discussed here, will be
ssociated with better outcomes than will occur in ASD
atients who have already developed substantial exercise
imitations or other complications such as arrhythmias. For
he vast majority of patients, the fears evoked in the surgical
ra for surgical closure of secundum ASDs can be left
ehind. Still, the relative ease of closure by device should not
e construed as justification for closing small ASDs in
atients who do not need treatment. Closure of secundum
SDs by device offers a quick and presumably lasting
enefit to appropriately selected adult patients with few or
o symptoms.
eprint requests and correspondence: Dr. Gary D. Webb,
oronto General Hospital, 200 Elizabeth Street, 12 EN-215,
oronto, Ontario M5G 2C4 Canada. E-mail: gary.webb@
hn.on.ca.
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